Literature DB >> 27732326

Genetic Variants in the Vitamin D Pathway, 25(OH)D Levels, and Mortality in a Large Population-Based Cohort Study.

José Manuel Ordóñez-Mena1,2,3, Haifa Maalmi1,2, Ben Schöttker1,2, Kai-Uwe Saum1, Bernd Holleczek4, Thomas J Wang5, Barbara Burwinkel6,7, Hermann Brenner1,2.   

Abstract

Context: Low 25-hydroxyvitamin D [25(OH)D] concentrations have been consistently associated with excess mortality in epidemiological studies, but this association could be due to confounding by health impairments associated with low 25(OH)D levels. An association of vitamin D-related genetic variants with all-cause mortality could strengthen the claims of causality, because this association is assumed to be unaffected by confounding. Objective: To assess the associations of low 25(OH)D with mortality in the presence or absence of genetic variants in the vitamin D pathway. Design, Setting, and Participants: The study consisted of a population-based cohort of 8417 German older adults in whom genetic variants were genotyped. Main Outcome Measures: The primary outcome measure was all-cause mortality.
Results: Two single nucleotide polymorphisms (SNPs), rs3755967 (GC) and rs11603330 (DHCR7), were associated with higher risk of low vitamin D status [odds ratio (95% confidence interval) per minor allele, 1.27 (1.18 to 1.36) and 1.16 (1.08 to 1.25), respectively]. Low 25(OH)D (less than the season-specific 33rd percentile) was associated with increased mortality. However, none of the SNPs was associated with increased mortality. Furthermore, the increase in mortality for those with low 25(OH)D was generally smaller in the presence of the risk alleles for low 25(OH)D ["genetically low 25(OH)D"] than in the absence of those risk alleles ["otherwise low 25(OH)D"]. Conclusions: Although we may have been limited by a low statistical power to detect small associations, our study showed that the strong relationship between low 25(OH)D and increased mortality may be at least partly due to other factors related to low 25(OH)D levels.
Copyright © 2017 by the Endocrine Society

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27732326     DOI: 10.1210/jc.2016-2468

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

Review 1.  Vitamin D deficiency accelerates ageing and age-related diseases: a novel hypothesis.

Authors:  Michael J Berridge
Journal:  J Physiol       Date:  2017-10-31       Impact factor: 5.182

Review 2.  Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions.

Authors:  Roger Bouillon; Claudio Marcocci; Geert Carmeliet; Daniel Bikle; John H White; Bess Dawson-Hughes; Paul Lips; Craig F Munns; Marise Lazaretti-Castro; Andrea Giustina; John Bilezikian
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

3.  Interactions between Vitamin D Genetic Risk and Dietary Factors on Metabolic Disease-Related Outcomes in Ghanaian Adults.

Authors:  Buthaina E Alathari; David A Nyakotey; Abdul-Malik Bawah; Julie A Lovegrove; Reginald A Annan; Basma Ellahi; Karani S Vimaleswaran
Journal:  Nutrients       Date:  2022-07-04       Impact factor: 6.706

Review 4.  The health effects of vitamin D supplementation: evidence from human studies.

Authors:  Roger Bouillon; Despoina Manousaki; Cliff Rosen; Katerina Trajanoska; Fernando Rivadeneira; J Brent Richards
Journal:  Nat Rev Endocrinol       Date:  2021-11-23       Impact factor: 47.564

5.  Genome-Wide Association Study of Serum 25-Hydroxyvitamin D in US Women.

Authors:  Katie M O'Brien; Dale P Sandler; Min Shi; Quaker E Harmon; Jack A Taylor; Clarice R Weinberg
Journal:  Front Genet       Date:  2018-03-01       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.